- Salary
- $345k – $365k/yr
- Location
- Boston, MA
- Workplace
- Hybrid
- Type
- Full-time
- Department
- Commercial
- Seniority
- VP
- Experience
- 7+ years
- Education
- Master
- Source
- Lever
Description
enGene (NASDAQ: ENGN) is a late-stage biotechnology company, mainstreaming genetic medicines through the delivery of therapeutics to mucosal tissues and other organs, whose lead product candidate, detalimogene voraplasmid, is being evaluated in an ongoing pivotal study for patients with non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (Cis) who are unresponsive to BCG. Detalimogene voraplasmid was developed using enGene’s proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of sizes and types of cargo, including DNA and various forms of RNA. For more information, visit enGene.com.
The Role
enGene is seeking a talented and dynamic commercial leader with a proven track record of launch experience to build and lead the company’s launch readiness marketing strategy and execution plan. Reporting to the Chief Global Commercialization Officer, the VP of Marketing, will lead and shape our brand strategy and market development ahead of commercialization This is one of the first commercial hires for the company and this leader will be instrumental in enGene’s evolution from the clinical stage to a commercial-stage biotech company.